Compound 1834
Identifiers
- Canonical SMILES:
Oc1ccc(cc1)-c1nc2sc3CCCCCc3c2c(=O)[nH]1
- IUPAC name:
5-(4-hydroxyphenyl)-8-thia-4,6-diazatricyclo[7.5.0.0^{2,7}]tetradeca-1(9),2(7),5-trien-3-one
- InChi:
InChI=1S/C17H16N2O2S/c20-11-8-6-10(7-9-11)15-18-16(21)14-12-4-2-1-3-5-13(12)22-17(14)19-15/h6-9,20H,1-5H2,(H,18,19,21)
- InChiKey:
HIPCDHDMFWCRML-UHFFFAOYSA-N
External links
![]() 136242352 |
![]() CHEMBL2397398 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 2 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
Bromodomain / Histone | 6.25 | breast cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 312.09 g/mol | |||
HBA | 4 | |||
HBD | 2 | |||
HBA + HBD | 6 | |||
AlogP | 4.30 | |||
TPSA | 61.69 | |||
RB | 1 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 2 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1021/acs.jmedchem.7b00275 | 7d | BRD4 O60885 |
H4 P62805 |
Biochemical assay | alphascreen BRD4 | pIC50 (half maximal inhibitory concentration, -log10) | 6.25 | |
10.1021/acs.jmedchem.7b00275 | 7d | BRD4 O60885 |
H4 P62805 |
Cellular assay | Anti-proliferative MCF-7 | MCF7 mammary carcinoma cells | pIC50 (half maximal inhibitory concentration, -log10) | 5.81 |
10.1021/acs.jmedchem.7b00275 | 7d | BRD4 O60885 |
H4 P62805 |
Cellular assay | Anti-proliferative MDA-MB-231 | MDA-MB-231 breast | pIC50 (half maximal inhibitory concentration, -log10) | 5.48 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.7833 | 5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE | DB08777 | |
0.6577 | 3-(1H-tetrazol-5-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one | DB06889 | |
0.6437 | (5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide | DB07397 | |
0.4045 | Sufugolix | DB06494 | |
0.4025 | DDP-225 | DB05642 | |
0.3805 | Relugolix | DB11853 | |
0.3691 | Sagopilone | DB12391 | |
0.3682 | 2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE | DB08789 | |
0.3673 | T-62 | DB12919 | |
0.3646 | Pelitrexol | DB12757 | |
0.3633 | Udenafil | DB06267 | |
0.3529 | 2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide | DB06969 | |
0.3514 | Raltitrexed | DB00293 | |
0.3512 | 5-ethoxy-4-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide | DB08729 | |
0.3462 | N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide | DB07217 |